Clinical Trial Update: Pre-exposure Prophylaxis for SARS-Coronavirus-2 [Phase 3]

View source ↗

Summary

Phase 3 trial update on pre-exposure prophylaxis for SARS-CoV-2 completed with posted results in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corona Virus Infection
• Respiratory Distress Syndrome

Snippet

Sponsor: University of Minnesota | Conditions: COVID-19, Corona Virus Infection | Phase 3 | Status: COMPLETED | Results posted: 2021-06-30